Chemotherapy-induced neutropenia and emerging agents for prevention and treatment: A review

被引：24
|
作者：
Blayney, Douglas W. [1 ,3 ]
Schwartzberg, Lee [2 ]
机构：
[1] Stanford Canc Inst, Stanford, CA 75216 USA
[2] Univ Nevada, Renown Inst Canc, Reno, NV USA
[3] 875 Blake Wilbur Dr,Room CC-2219,M-C 6576, Stanford, CA 94305 USA
来源：
CANCER TREATMENT REVIEWS | 2022年 / 109卷
关键词：
Chemotherapy -induced neutropenia; G-CSF; Trilaciclib; Plinablin; Efbemalenograstim alpha; Eflapegrastim; INDUCED FEBRILE NEUTROPENIA; COLONY-STIMULATING FACTOR; RELATIVE DOSE INTENSITY; PER-CYCLE PEGFILGRASTIM; US CLINICAL-PRACTICE; BREAST-CANCER; PRIMARY PROPHYLAXIS; PLINABULIN PLIN; BIOSIMILAR FILGRASTIM; RECEIVING CHOP;
D O I：
10.1016/j.ctrv.2022.102427
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页数：10
相关论文
共 50 条
  • [1] Prevention and Treatment of Chemotherapy-Induced Febrile Neutropenia in Adults
    Park, Hye Min
    Pom, Boramey
    Farina, Kyle A.
    Rattu, Mohammad A.
    US PHARMACIST, 2023, 48 (04)
  • [2] Prevention and Treatment of Chemotherapy-Induced Febrile Neutropenia in Adults
    Park, Hye Min
    Pom, Boramey
    Farina, Kyle A.
    Rattu, Mohammad A.
    US PHARMACIST, 2023, 48 (06) : 25 - 30
  • [3] Emerging agents for the prevention of treatment induced neutropenia in adult cancer patients
    Matikas, Alexios
    Georgoulias, Vassilis
    Kotsakis, Athanasios
    EXPERT OPINION ON EMERGING DRUGS, 2016, 21 (02) : 157 - 166
  • [4] Eflapegrastim (Rolvedon) for Prevention of Chemotherapy-Induced Febrile Neutropenia
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023, 65 (1677): : 83 - 84
  • [5] Prevention of chemotherapy-induced neutropenia by special honey intake
    Zidan, Jamal
    Shetver, Lika
    Gershuny, Anthony
    Abzah, Amira
    Tamam, Sigalit
    Stein, Moshe
    Friedman, Eitan
    MEDICAL ONCOLOGY, 2006, 23 (04) : 549 - 552
  • [6] Prevention of chemotherapy-induced neutropenia by special honey intake
    Jamal Zidan
    Lika Shetver
    Anthony Gershuny
    Amira Abzah
    Sigalit Tamam
    Moshe Stein
    Eitan Friedman
    Medical Oncology, 2006, 23 : 549 - 552
  • [7] A comparison of international guidelines for the prevention of chemotherapy-induced neutropenia
    Lyman, Gary H.
    CURRENT OPINION IN HEMATOLOGY, 2011, 18 (01) : 1 - 10
  • [8] Prevention and treatment of chemotherapy-induced nausea and vomiting: A review
    DiVall, Margarita V.
    Cersosimo, Robert J.
    FORMULARY, 2007, 42 (06) : 378 - +
  • [9] Pegfilgrastim: a review of the pharmacoeconomics for chemotherapy-induced neutropenia
    Rofail, Pierre
    Tadros, Mariam
    Ywakim, Riham
    Tadrous, Mina
    Krug, Allison
    Cosler, Leon E.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2012, 12 (06) : 699 - 709
  • [10] Lipegfilgrastim for the prophylaxis and treatment of chemotherapy-induced neutropenia
    Ratti, Margherita
    Tomasello, Gianluca
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2015, 8 (01) : 15 - 24
12345